p1A Prk-
(Plasmid
#162694)
-
Purposep1A negative control expressing CbbLS and inactive Prk (Prk K20M S21A)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 162694 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFE21 (derived from pZE21expressing under PLtet0-1 and constitutive tetR)
- Backbone size w/o insert (bp) 3127
- Total vector size (bp) 5986
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsDo not induce with aTc in LB, it will induce prk toxicity. If you want to express the genes do so in minimal media.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameH. neapolitanus CbbLS and S. elongatus Prk
-
SpeciesH. neapolitanus and S. elongatus
-
Insert Size (bp)2859
-
MutationPrk inactive (K20M S21A native protein, this map has a 6x N-terminal His tagged PRK so its K26M, S27A)
- Promoter PLtet0-1 promoter
-
Tag
/ Fusion Protein
- N terminal 6x His tag on PRK (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer gaaagccatccagtttactttgca
- 3′ sequencing primer GCGTTCACCGACAAACAACA (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This plasmid contains a Prk K20M S21A mutation rendering Prk inactive.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
p1A Prk- was a gift from David Savage (Addgene plasmid # 162694 ; http://n2t.net/addgene:162694 ; RRID:Addgene_162694) -
For your References section:
Functional reconstitution of a bacterial CO2 concentrating mechanism in E. coli. Flamholz AI, Dugan E, Blikstad C, Gleizer S, Ben-Nissan R, Amram S, Antonovsky N, Ravishankar S, Noor E, Bar-Even A, Milo R, Savage D. Elife. 2020 Oct 21;9. pii: 59882. doi: 10.7554/eLife.59882. 10.7554/eLife.59882 PubMed 33084575